Hospital at Home Biofourmis’ AI-driven platform continuously monitors 120+ biomarkers to deliver hospital-level care at home, enabling scalable RPM and remote patient management. With proven collaborations such as AdventHealth and Epic EHR integration, the solution is well-positioned to expand across health systems and payers seeking to reduce readmissions and extend care into post-acute settings.

Digital Therapeutics Strategic focus on digital therapeutics and remote trials is evident in recent moves: Biofourmis acquired PhysioWave for heart-care digital therapy and merged with CopilotIQ to launch an AI-powered in-home care platform. The January 2025 acquisition of Biofourmis Connect by ActiGraph signals continued ecosystem consolidation, creating opportunities to offer digital-trial platforms, remote monitoring data, and integrated solutions to life sciences sponsors.

Interoperability Advantage Epic EHR interoperability is a differentiator: integration with Lee Health’s Epic system enables continuity of care data from home and real-time insights, making Biofourmis attractive to Epic-adopter health systems and health plans seeking seamless data flows and provider workflow efficiency.

M&A Momentum M&A momentum in 2024–25 indicates buyers are seeking end-to-end digital care platforms. This creates opportunities to partner with ActiGraph or align with Biofourmis’ evolving platform for customers navigating vendor changes, reducing risk and accelerating adoption.

Global Delivery Global footprint with headquarters in Boston and offices in Singapore and India positions Biofourmis for multi-market deployments, enabling scalable remote care across US, APAC, and emerging markets for health systems, payers, and global life sciences programs.